RxDoctor Payments DataLook up a doctor →

IMFINZI: payments to doctors

Payments that named IMFINZI as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$165.3M
Providers
16,273
Transactions
65,505
Average per transaction
$2,524

The per-transaction average — $2,524 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 16,273 providers the average total is $10,158, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
AstraZeneca$110,566,19866.9%
Astrazeneca UK Limited$54,663,91333.1%
Astrazeneca AB$61,5720.0%
Acerta Pharma LLC$13,9420.0%
← All drugs & devices